U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
Category: Competitor News
Tempus Announces Sequencing Collaboration With Lilly to Expand Access to Genomic Testing
June 09, 2022 10:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed...
Hot off its Cerner acquisition, Oracle is developing a national health records database
Two days after it completed its $28.4 billion acquisition of Cerner, Oracle announced plans to build a national, anonymized health information management system. By KATIE ADAMS Post a comment / Jun 9,...
U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
June 09, 2022 01:03 ET | Source: F. Hoffmann-La Roche Ltd FoundationOne CDx can now be used to identify patients with ROS1 fusion-positive non-small cell lung cancer or patients with NTRK fusion-positive solid tumours for whom...
IQVIA Appoints Dr. Christina Mack Chief Scientific Officer of Real World Solutions
June 07, 2022 08:00 AM Eastern Daylight Time RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences...
COVID-19 Research Database Partners with the HHS Technology Group to Create a Scalable, Repeatable Model for Research
SAN FRANCISCO and FORT LAUDERDALE, Fla., June 07, 2022 (GLOBE NEWSWIRE) — The COVID-19 Research Database (the Database), a pro bono initiative led by numerous prominent companies whose mission is...
GE Healthcare and National Cancer Centre Singapore collaborate on AI-driven research to improve cancer care
Singapore – 7 June 2022: GE Healthcare today announces a new collaboration with National Cancer Centre Singapore (NCCS), which focuses on how artificial intelligence (AI) driven research can be used to...
EVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life Sciences
CHICAGO, June 7, 2022 /PRNewswire/ — EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry, today unveiled EVERSANA INTOUCH, marking the transformation of its full-service, global healthcare agency network serving the...
BC Platforms Drives Data Enablement and Collaboration to Accelerate Precision Medicine in Asia
Global healthcare data management and analytics leader brings together experts to discuss current drivers in personalized medicine at second edition of Precision Medicine & Data Science Conference in Singapore ZURICH, June 6, 2022 /PRNewswire/ — BC Platforms (BCP),...
Foundation Medicine Announces Strategic Collaboration with Arvinas
Initial Goal of Collaboration is to Develop FoundationOne®Liquid CDx as a Companion Diagnostic for Bavdegalutamide (ARV-110), Arvinas’ Investigational Androgen Receptor-Targeting PROTAC® Protein Degrader June 05, 2022 08:05 AM Eastern Daylight...